Toggle navigation
Home
Search
Services
Blog
Contact
About
Preventing Retinal Neovascularization with Nrts
Narducy, Kenneth W.
Centaur Pharmaceuticals, Inc., Sunnyvale, CA, United States
Search 16 grants from Kenneth Narducy
Search grants from Centaur Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neuromodulation and Cortical Memory Function
Sam68 and HIV-1 replication control in astrocytes
Developmental regulation of neural circuit properties
Selectin in Experimental Allergic Encephalomyelitis
Genetic Factors in Contributing to Cad and Its Risk Factors
Recently added grants:
Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis.
Electronic cigarettes in Latin America: Evaluation of impacts and policy options
Husbandry and Management Core
Viral Testing Core
MHC Genetic Typing Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY011061-01A1
Application #
2165317
Study Section
Special Emphasis Panel (ZRG1-VISA (01))
Project Start
1996-07-01
Project End
1997-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Centaur Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Sunnyvale
State
CA
Country
United States
Zip Code
94085
Comments
Be the first to comment on Kenneth Narducy's grant